Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo.

@article{Mathias2000HealthrelatedQO,
  title={Health-related quality of life and functional status of patients with rheumatoid arthritis randomly assigned to receive etanercept or placebo.},
  author={Susan D. Mathias and Hilary H. Colwell and Dave P. Miller and Larry Moreland and Mary C Buatti and Lee Wanke},
  journal={Clinical therapeutics},
  year={2000},
  volume={22 1},
  pages={128-39}
}
OBJECTIVE To compare the functional status and well-being of patients with rheumatoid arthritis (RA) who were randomly assigned to receive placebo, etanercept 10 mg, or etanercept 25 mg during a 26-week, phase III, double-blind clinical trial. BACKGROUND No single indicator of disease activity, severity, or therapeutic efficacy has been established for RA. During the past decade, health-related quality of life, a multidimensional way to assess physical, emotional, and social aspects of a… CONTINUE READING